FR4673M - - Google Patents

Info

Publication number
FR4673M
FR4673M FR17572A FR17572A FR4673M FR 4673 M FR4673 M FR 4673M FR 17572 A FR17572 A FR 17572A FR 17572 A FR17572 A FR 17572A FR 4673 M FR4673 M FR 4673M
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR17572A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to FR17572A priority Critical patent/FR4673M/fr
Priority to US550098A priority patent/US3426131A/en
Priority to BE681198D priority patent/BE681198A/xx
Priority to GB22104/66A priority patent/GB1093546A/en
Application granted granted Critical
Publication of FR4673M publication Critical patent/FR4673M/fr
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/63One oxygen atom
    • C07D213/65One oxygen atom attached in position 3 or 5
    • C07D213/66One oxygen atom attached in position 3 or 5 having in position 3 an oxygen atom and in each of the positions 4 and 5 a carbon atom bound to an oxygen, sulphur, or nitrogen atom, e.g. pyridoxal
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B29WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29CSHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C53/00Shaping by bending, folding, twisting, straightening or flattening; Apparatus therefor
    • B29C53/56Winding and joining, e.g. winding spirally
    • B29C53/58Winding and joining, e.g. winding spirally helically
    • B29C53/60Winding and joining, e.g. winding spirally helically using internal forming surfaces, e.g. mandrels

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Mechanical Engineering (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR17572A 1965-05-19 1965-05-19 Expired FR4673M (fr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
FR17572A FR4673M (fr) 1965-05-19 1965-05-19
US550098A US3426131A (en) 1965-05-19 1966-05-16 Medicament based on a salt of pyridoxamine
BE681198D BE681198A (fr) 1965-05-19 1966-05-18
GB22104/66A GB1093546A (en) 1965-05-19 1966-05-18 Pyridoxamine salts

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR17572A FR4673M (fr) 1965-05-19 1965-05-19

Publications (1)

Publication Number Publication Date
FR4673M true FR4673M (fr) 1966-12-19

Family

ID=8579115

Family Applications (1)

Application Number Title Priority Date Filing Date
FR17572A Expired FR4673M (fr) 1965-05-19 1965-05-19

Country Status (4)

Country Link
US (1) US3426131A (fr)
BE (1) BE681198A (fr)
FR (1) FR4673M (fr)
GB (1) GB1093546A (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5288716A (en) * 1987-02-18 1994-02-22 Ulrich Speck Use of pyridoxine derivatives in the prevention and treatment of hyperlipidaemia and atherosclerosis
US6740668B1 (en) 1995-08-28 2004-05-25 Kansas University Medical Center Methods for inhibiting diabetic complications
US6716858B1 (en) 1995-08-28 2004-04-06 Kansas University Medical Center Methods for inhibiting diabetic complications
US6228858B1 (en) 1995-09-12 2001-05-08 University Of Kansas Medical Center Advanced glycation end-product intermediaries and post-amadori inhibition
US6750209B1 (en) 1995-09-12 2004-06-15 Kansas University Medical Center Advanced glycation end-product intermediaries and post-amadori inhibition
US5744451A (en) 1995-09-12 1998-04-28 Warner-Lambert Company N-substituted glutamic acid derivatives with interleukin-1 β converting enzyme inhibitory activity
US6730686B1 (en) 1995-09-12 2004-05-04 Kansas University Medical Center Methods for inhibiting oxidative modification of proteins
US7030146B2 (en) 1996-09-10 2006-04-18 University Of South Carolina Methods for treating diabetic neuropathy
AU1444600A (en) * 1998-10-09 2000-05-01 Kansas University Medical Center Methods for inhibiting oxidative modification of proteins

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2955115A (en) * 1955-06-13 1960-10-04 Fred A Kummerow Long-chain fatty acid esters of vitamin b6

Also Published As

Publication number Publication date
BE681198A (fr) 1966-10-31
GB1093546A (en) 1967-12-06
US3426131A (en) 1969-02-04

Similar Documents

Publication Publication Date Title
BE673125A (fr)
BE675324A (fr)
AU416352B2 (fr)
BE672840A (fr)
BE675322A (fr)
BE664767A (fr)
BE665744A (fr)
BE668297A (fr)
BE668917A (fr)
BE669447A (fr)
BE669475A (fr)
BE669636A (fr)
BE671240A (fr)
BE671348A (fr)
BE671386A (fr)
BE671387A (fr)
BE671454A (fr)
BE671734A (fr)
BE671749A (fr)
BE671856A (fr)
BE672238A (fr)
BE672573A (fr)
BE672778A (fr)
BE674836A (fr)
BE658570A (fr)